# Centauri Therapeutics Limited

**Private**

**United Kingdom**  
**Healthcare & Life Sciences** [Centauri Therapeutics Website](https://www.centauritherapeutics.com/)

**Last Round**  
Series A Extension  
Feb 24, 2026

**Total Funding Raised**  
$58.06M

## Company Overview

Centauri Therapeutics Limited is a biotechnology company that develops novel immunotherapies for infectious diseases and oncology using its proprietary Alphamer platform technology.

**Sector:**  Healthcare & Life Sciences  
**Verticals:**  Biotechnology, Drug Discovery  
**Business Model:**  B2B  
**Customer Profile:**  Services & Consulting, Data as a Service  
**AI Layer:**  Non-AI  
**Keywords:**  immunotherapy, antimicrobial resistance, AMR, drug discovery, bifunctional molecules, superbug treatment, antibody recruiting, biotech startup, oncology, infectious disease, preclinical development, drug pipeline, pharma licensing, biotech platform

## Historical Pricing

Historical view of private secondary pricing and transaction trends.

### Pricing Charts

## Centauri Therapeutics Limited Comparables

Compare Centauri Therapeutics Limited with similar companies based on industry and business-model similarity.

| Company | Similarity | Market Cap |
| --- | --- | --- |
| [Clarametyx Biosciences](/content/company/clarametyx-biosciences/index.html) | 79% |  |
| [Infex Therapeutics](/content/company/infextx/index.html) | 77% |  |
| Aurobac Therapeutics | 76% |  |
| Comparable company | 50% |  |

## Centauri Therapeutics Limited Funding Rounds

Historical fundraising activity

| Round | Date | Amount Raised | Valuation | Investors | Sources |
| --- | --- | --- | --- | --- | --- |
| Series A Extension | Feb 24, 2026 |  |  |  |  |
| Grant | Jul 29, 2025 |  |  |  |  |
| Grant | Nov 25, 2024 |  |  |  |  |
| Grant | Feb 22, 2022 |  |  |  |  |
| Series A | Feb 16, 2022 |  |  |  |  |
| Grant | Jan 7, 2020 |  |  |  |  |

## Key People

Founding team and executive leadership

**Samantha Macro**  
*CFO*  
[LinkedIn profile](https://www.linkedin.com/in/samanthamacro)

## Centauri Therapeutics Limited Investors

Notable investors and investment history

| Investor | Rounds |
| --- | --- |
| [AMR Action Fund](/content/investor/amractionfund/index.html) | Series A Extension |
| [Boehringer Ingelheim](/content/investor/boehringer-ingelheim/index.html) | Series A Extension, Series A |
| [PACE (Pathways to Antimicrobial Clinical Efficacy)](/content/investor/paceamr-org/index.html) | Grant |
| [CARB-X](/content/investor/carb-x/index.html) | Series A Extension, Grant |
| [Innovate UK](/content/investor/ukri-org/index.html) | Grant |
| [Medicines Discovery Catapult](/content/investor/medicines-discovery-catapult/index.html) | Grant |
| [Novo Holdings](/content/investor/novo-holdings-1/index.html) | Series A Extension, Series A |

## Market signals

Structured signals derived from secondary market and firmographic data.

- Jul 29, 2025  
  $5.1M grant from CARB-X

- Jul 29, 2025  
  Developing ABX-01 programme, a broad-spectrum antimicrobial.

## Centauri Therapeutics Limited Filings

SEC and related filings with document metadata.

| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
| --- | --- | --- | --- | --- | --- | --- |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |

## Frequently Asked Questions

Common questions about Centauri Therapeutics Limited's valuation, stock price, and market status.

- Is Centauri Therapeutics Limited a public or private company?  
- What is the current stock price of Centauri Therapeutics Limited?  
- How much is Centauri Therapeutics Limited worth (valuation)?  
- Can I buy Centauri Therapeutics Limited stock?  
- When was Centauri Therapeutics Limited's last funding round?  
- Who are the main investors in Centauri Therapeutics Limited?  
- Will Centauri Therapeutics Limited IPO soon?  
- How can I track Centauri Therapeutics Limited secondary market activity?

## Firmographic Details

**Headquarters:** United Kingdom  
**Employee Range:** 26  
**Year Founded:** 2014  
**Last Funding:** Feb 24, 2026